United States · FDA National Drug Code directory
Lisinopril
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 43063-812_415b9940-77ea-a174-e063-6294a90a4cfe
- Product NDC
- 43063-812
- Form
- TABLET
- Composition / generic term
- Lisinopril
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170830
- Source listing expiry
- 20261231
Source-listed ingredients
- LISINOPRIL — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE, PLASTIC (43063-812-01) · 43063-812-01
- 12 TABLET in 1 BOTTLE, PLASTIC (43063-812-12) · 43063-812-12
- 14 TABLET in 1 BOTTLE, PLASTIC (43063-812-14) · 43063-812-14
- 30 TABLET in 1 BOTTLE, PLASTIC (43063-812-30) · 43063-812-30
- 60 TABLET in 1 BOTTLE, PLASTIC (43063-812-60) · 43063-812-60
- 90 TABLET in 1 BOTTLE, PLASTIC (43063-812-90) · 43063-812-90
- 180 TABLET in 1 BOTTLE, PLASTIC (43063-812-93) · 43063-812-93
- 120 TABLET in 1 BOTTLE, PLASTIC (43063-812-98) · 43063-812-98
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →